日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Regioselective Synthesis of 5-Substituted 3-(β-d-Glycopyranosyl)isoxazoles and -isoxazolines by 1,3-Dipolar Cycloaddition as Potential Anticancer Agents and Glycogen Phosphorylase Inhibitors

通过1,3-偶极环加成反应区域选择性合成5-取代的3-(β-D-吡喃糖基)异噁唑和异噁唑啉作为潜在的抗癌剂和糖原磷酸化酶抑制剂

Kaszás, Tímea; Szakács, Bence; Bertalan, Márta; Blága, Tekla; Hameed, Faria; Lengyel, Ákos; Saifi, Samreen; Juhász-Tóth, Éva; Varga, Luca A; Docsa, Tibor; Sipos, Adrienn; Bai, Péter; Ábrahám, Anita; Kiss-Szikszai, Attila; Kun, Sándor; Kiss, György Attila; József, János; Juhász, László; Tóth, Marietta

Synthesis, In Silico and Kinetics Evaluation of N-(β-d-glucopyranosyl)-2-arylimidazole-4(5)-carboxamides and N-(β-d-glucopyranosyl)-4(5)-arylimidazole-2-carboxamides as Glycogen Phosphorylase Inhibitors

N-(β-D-吡喃葡萄糖基)-2-芳基咪唑-4(5)-甲酰胺和N-(β-D-吡喃葡萄糖基)-4(5)-芳基咪唑-2-甲酰胺作为糖原磷酸化酶抑制剂的合成、计算机模拟和动力学评价

Homolya, Levente; Mathomes, Rachel T; Varga, Luca; Docsa, Tibor; Juhász, László; Hayes, Joseph M; Somsák, László

Design and Synthesis of 3-(β-d-Glucopyranosyl)-4-amino/4-guanidino Pyrazole Derivatives and Analysis of Their Glycogen Phosphorylase Inhibitory Potential

3-(β-D-吡喃葡萄糖基)-4-氨基/4-胍基吡唑衍生物的设计与合成及其糖原磷酸化酶抑制活性的分析

Kun, Sándor; Mathomes, Rachel T; Docsa, Tibor; Somsák, László; Hayes, Joseph M

Stretch-Induced Down-Regulation of HCN2 Suppresses Contractile Activity

拉伸诱导的HCN2下调抑制收缩活动

Job Baffin Kola, Botagoz Turarova, Dora Csige, Ádám Sipos, Luca Varga, Bence Gergely, Farah Al Refai, Iván P Uray, Tibor Docsa, Karen Uray

The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders

炎症介质在胃肠动力障碍发展中的作用

Docsa, Tibor; Sipos, Adám; Cox, Charles S; Uray, Karen

Dual-Target Compounds against Type 2 Diabetes Mellitus: Proof of Concept for Sodium Dependent Glucose Transporter (SGLT) and Glycogen Phosphorylase (GP) Inhibitors

针对 2 型糖尿病的双靶点化合物:钠依赖性葡萄糖转运蛋白 (SGLT) 和糖原磷酸化酶 (GP) 抑制剂的概念验证

Ádám Sipos, Eszter Szennyes, Nikolett Éva Hajnal, Sándor Kun, Katalin E Szabó, Karen Uray, László Somsák, Tibor Docsa, Éva Bokor

Glycogen phosphorylase inhibitor, 2,3-bis[(2E)-3-(4-hydroxyphenyl)prop-2-enamido] butanedioic acid (BF142), improves baseline insulin secretion of MIN6 insulinoma cells

糖原磷酸化酶抑制剂 2,3-双[(2E)-3-(4-羟基苯基)丙-2-烯酰胺]丁二酸 (BF142) 可改善 MIN6 胰岛素瘤细胞的基线胰岛素分泌

Lilla Nagy, Ferenc Béke, László Juhász, Tünde Kovács, Éva Juhász-Tóth, Tibor Docsa, Attila Tóth, Pál Gergely, László Somsák, Péter Bai

Glycogen phosphorylase inhibition improves beta cell function

糖原磷酸化酶抑制可改善β细胞功能

Lilla Nagy, Judit Márton, András Vida, Gréta Kis, Éva Bokor, Sándor Kun, Mónika Gönczi, Tibor Docsa, Attila Tóth, Miklós Antal, Pál Gergely, Balázs Csóka, Pal Pacher, László Somsák, Péter Bai2

Synthesis of New C- and N-β-d-Glucopyranosyl Derivatives of Imidazole, 1,2,3-Triazole and Tetrazole, and Their Evaluation as Inhibitors of Glycogen Phosphorylase

咪唑、1,2,3-三唑和四唑的新型C-和N-β-D-吡喃葡萄糖基衍生物的合成及其作为糖原磷酸化酶抑制剂的评价

Kun, Sándor; Bokor, Éva; Sipos, Ádám; Docsa, Tibor; Somsák, László

4(5)-Aryl-2-C-glucopyranosyl-imidazoles as New Nanomolar Glucose Analogue Inhibitors of Glycogen Phosphorylase

4(5)-芳基-2-C-吡喃葡萄糖基-咪唑类化合物作为新型纳摩尔级葡萄糖类似物糖原磷酸化酶抑制剂

Bokor, Éva; Kun, Sándor; Docsa, Tibor; Gergely, Pál; Somsák, László